DRI and Foundation News

DRI tv

November 2019 marks the 25-year partnership of the DRI and Biorep.

Ryan Ward and his dad describe their experience in the POSEIDON study. 

Sharing innovative ways to regulate the immune system. 

By understanding the biology of T1D, scientists can create new therapeutics. 

Dr. Bendala reported on recent breakthroughs while in Spain.

Do we all have islet autoimmunity? Dr. Roberto Mallone explains.

New study points to microRNAs as biomarkers of islet autoimmunity.

Dr. Alberto Pugliese will advocate for increased T1D funding

First patient in DRI BioHub trial off insulin therapy in record time.

What is so exciting about mesenchymal stem cells (MSCs)?

Is the pancreas regeneration debate settled?

DRI Federation adds new members to accelerate islet transplantation. 

The new F-Word and its connection to diabetes. 

DRI scientists identify possible early predictor of T1D onset and progression.

Dr. Chris Fraker is working to provide oxygen to encapsulated islets.

Tiny cell messengers may help halt autoimmunity in T1D.

The DRI is testing the omentum as an alternative transplant site.

DRI launches POSEIDON trial to assess omega-3 and vitamin D in T1D. 

DRI and collaborator studies led to the new low-dose IL-2 trial. 

Visiting professor Dr. Chantal Mathieu talks about T1D prevention, vitamin D.

Dr. Ricordi will discuss future directions in regenerative medicine and stem cells.

Exosomes may serve as biomarkers of T1D and also deliver agents to cells.

Dr. Allison Bayer awarded grants to advance tolerance research.

Investigating biliary tree stem cells as a source of insulin-producing cells.

Keep up with our progress toward a cure & more

Be a DRI Insider - Get News!